WallStreetZenWallStreetZen

NASDAQ: PLRX
Pliant Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for PLRX

Based on 3 analysts offering 12 month price targets for Pliant Therapeutics Inc.
Min Forecast
$38.00+211.73%
Avg Forecast
$46.67+282.83%
Max Forecast
$54.00+342.99%

Should I buy or sell PLRX stock?

Based on 3 analysts offering ratings for Pliant Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
3 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PLRX stock forecasts and price targets.

PLRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-10
lockedlocked$00.00+00.00%2024-03-05
lockedlocked$00.00+00.00%2024-02-28

1 of 1

Forecast return on equity

Is PLRX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is PLRX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

PLRX revenue forecast

What is PLRX's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$120.3M+7,514.43%
Avg 2 year Forecast
$370.5M+23,346.2%
Avg 3 year Forecast
$848.5M+53,601.58%
PLRX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PLRX revenue growth forecast

How is PLRX forecast to perform vs Biotechnology companies and vs the US market?
Company
45.4%
Industry
37.96%
Market
10.23%
PLRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PLRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PLRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PLRX$12.19$46.67+282.83%Buy
ELVN$17.67$34.00+92.42%Strong Buy
IRON$30.02$69.60+131.85%Buy
PRTC$26.94N/AN/A
CRGX$19.10$29.67+55.32%Strong Buy
View Top Biotech Stocks

Pliant Therapeutics Stock Forecast FAQ

Is Pliant Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: PLRX) stock is to Buy PLRX stock.

Out of 3 analysts, 0 (0%) are recommending PLRX as a Strong Buy, 3 (100%) are recommending PLRX as a Buy, 0 (0%) are recommending PLRX as a Hold, 0 (0%) are recommending PLRX as a Sell, and 0 (0%) are recommending PLRX as a Strong Sell.

If you're new to stock investing, here's how to buy Pliant Therapeutics stock.

What is PLRX's revenue growth forecast for 2027-2029?

(NASDAQ: PLRX) Pliant Therapeutics's forecast annual revenue growth rate of 45.4% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Pliant Therapeutics's revenue in 2024 is $1,580,000.On average, 3 Wall Street analysts forecast PLRX's revenue for 2027 to be $7,247,254,786, with the lowest PLRX revenue forecast at $2,874,974,914, and the highest PLRX revenue forecast at $11,462,310,409. On average, 3 Wall Street analysts forecast PLRX's revenue for 2028 to be $22,315,602,749, with the lowest PLRX revenue forecast at $3,650,494,066, and the highest PLRX revenue forecast at $42,081,281,178.

In 2029, PLRX is forecast to generate $51,112,037,248 in revenue, with the lowest revenue forecast at $22,414,997,390 and the highest revenue forecast at $79,809,077,107.

What is PLRX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: PLRX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is PLRX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year PLRX price target, the average PLRX price target is $46.67, with the highest PLRX stock price forecast at $54.00 and the lowest PLRX stock price forecast at $38.00.

On average, Wall Street analysts predict that Pliant Therapeutics's share price could reach $46.67 by Apr 10, 2025. The average Pliant Therapeutics stock price prediction forecasts a potential upside of 282.83% from the current PLRX share price of $12.19.

What is PLRX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: PLRX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.